| Website | sofinnova.fr |
| Phone | +33 (0)1 5305-4100 |
| Employees |
Sofinnova Partners based in Paris since 1972 is an independent venture capital company. It enjoys special relations with Sofinnova Ventures, a sister firm based in San Francisco. Primary investment focus includes information technologies and life sciences, in France and in other European countries, with a limited portion of investments in the US. Sofinnova invests in start-ups and early-stage companies with ambitious projects, with a preference for projects that may attract European investors. Sofinnova takes an active part on the board of directors, and bring added value to the management team.
| Company | Date | Round | Size | Participants |
| Flexion Therapeutics | 10/09 | Series A | $33M | 3 |
| mxp4 | 5/09 | Unattributed | $2.7M | 2 |
| Streamezzo | 5/09 | Series D | $5.45M | 6 |
| Neosens | 3/09 | Series B | $5.32M | 5 |
| GlycoVaxyn | 3/09 | Series B | $21.3M | 3 |
| mydeco | 8/08 | Series A | £7.35M | 4 |
| Qosmos | 4/08 | Series C | $10.9M | 3 |
| Mobile Digital Media | 3/08 | Unattributed | $2M | 2 |
| Laszlo Systems | 3/08 | Series C | $14.6M | 4 |
| Streamezzo | 12/07 | Series C | $22M | 7 |
| mxp4 | 2007 | Unattributed | $6.3M | 2 |
| blueKiwi | 2007 | Series A | $5.5M | 2 |
| Laszlo Systems | 4/05 | Series B | $6.25M | 3 |